Ranolazine
- Product NDC
- 60687-460
- 11-digit product format
- 606870460
- Labeler code
- 60687
- Product ID
- 60687-460_9a266f39-716a-69f5-e053-2a95a90a91fc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ranolazine
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- American Health Packaging
- Application
- ANDA201046
- Marketing category
- ANDA
- Marketing start
- 2019-12-16
- Marketing end
- 0000-00-00
- Substance
- RANOLAZINE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Anti-anginal [EPC],Cytochrome P450 3A Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record